Lack of association of a functional single nucleotide polymorphism of PTPN22, encoding lymphoid protein phosphatase, with susceptibility to Henoch-Schölein purpura

Clinical and Experimental Rheumatology

Volumn 25, Issue 5, 2007, Pages 750-753

  Orozco, Gisela ^a   Miranda Filloy, Jose A ^b   Martin, Javier ^a   Gonzalez Gay, Miguel A ^b  

^a CSIC   (Spain)

^b The Division of Rheumatology   (Spain)

Author keywords

Cutaneous vasculitis; Henoch Sch nlein purpura; Lymphoid tyrosine phosphatase; Nephritis; Polymorphism; PTPN22 gene; Susceptibility

Indexed keywords

CYTOSINE; PHOSPHATASE; PROTEIN TYROSINE PHOSPHATASE NON RECEPTOR 22; THYMINE; UNCLASSIFIED DRUG;

ADOLESCENT; ADULT; ANAPHYLACTOID PURPURA; ARTICLE; CAUCASIAN; CHILD; CONTROLLED STUDY; DISEASE PREDISPOSITION; DISEASE SEVERITY; FEMALE; FOLLOW UP; GASTROINTESTINAL DISEASE; GENE FREQUENCY; GENOTYPE; HUMAN; KIDNEY DISEASE; MAJOR CLINICAL STUDY; MALE; NEPHRITIS; PATIENT CODING; PRIORITY JOURNAL; REAL TIME POLYMERASE CHAIN REACTION; SINGLE NUCLEOTIDE POLYMORPHISM; SPAIN; SYSTEMIC VASCULITIS;

ADOLESCENT; ADULT; CASE-CONTROL STUDIES; CHILD; CHILD, PRESCHOOL; EUROPEAN CONTINENTAL ANCESTRY GROUP; FEMALE; GENETIC PREDISPOSITION TO DISEASE; GENOTYPE; HUMANS; MALE; MIDDLE AGED; POLYMORPHISM, SINGLE NUCLEOTIDE; PROTEIN TYROSINE PHOSPHATASE, NON-RECEPTOR TYPE 22; PURPURA, SCHOENLEIN-HENOCH; SPAIN;

EID: 37349027280     PISSN: 0392856X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (20)

1. CALVIÑO MC, LLORCA J, GARCIA-PORRUA C, FERNANDEZ-IGLESIAS JL, RODRIGUEZ-LEDO P, GONZALEZ-GAY MA: Henoch-Schönlein purpura in children from northwestern Spain: A 20-year epidemiologic and clinical study. Medicine (Baltimore) 2001; 80: 279-90.
2. GARCIA-PORRUA C, CALVINO MC, LLORCA J, COUSELO JM, GONZALEZ-GAY MA: Henoch-Schönlein purpura in children and adults: Clinical differences in a defined population. Semin Arthritis Rheum 2002; 32: 149-56.
3. GONZALEZ-GAY MA, CALVIÑO MC, VAZQUEZ-LOPEZ ME et al.: Implications of upper respiratory tract infections and drugs in the clinical spectrum of Henoch-Schönlein purpura in children. Clin Exp Rheumatol 2004; 22: 781-4
4. AMOLI MM, MARTIN J, MIRANDA-FILLOY JA, GARCIA-PORRUA C, OLLIER WE, GONZALEZ-GAY MA: Lack of association between macrophage migration inhibitory factor gene (-173 G/C) polymorphism and cutaneous vasculitis. Clin Exp Rheumatol 2006; 24: 576-9.
5. AMOLI MM, MARTIN J, MIRANDA-FILLOY JA, GARCIA-PORRUA C, OLLIER WE, GONZALEZ-GAY MA: Lack of association between interleukin-6 promoter polymorphism at position -174 and Henoch-Schönlein purpura. Clin Exp Rheumatol 2007; 25 (Suppl. 44): 6-8.
6. AMOLI MM, THOMSON W, HAJEER AH et al.: HLA-DRB1*01 association with Henoch-Schönlein purpura in patients from Northwest Spain. J Rheumatol 2001; 28: 1266-270.
7. AMOLI MM, MATTEY DL, CALVIÑO MC et al.: Polymorphism at codon 469 of the intercellular adhesion molecule-1 (ICAM-1) locus is associated with protection against severe gastrointestinal complications in Henoch-Schönlein purpura. J Rheumatol 2001; 28: 1014-8.
8. AMOLI MM, THOMSON W, HAJEER AH et al.: HLA-B35* association with nephritis in Henoch-Schönlein purpura. J Rheumatol 2002; 29: 948-9.
9. AMOLI MM, THOMSON W, HAJEER AH et al.: Interleukin-1 receptor antagonist gene polymorphism is associated with severe renal involvement and renal sequelae in Henoch-Schönlein purpura. J Rheumatol 2002; 29: 1404-07.
10. MARTIN J, PACO L. RUIZ MP et al.: Inducible nitric oxide synthase polymorphism is associated with susceptibility to Henoch-Schönlein purpura in northwestern Spain. J Rheumatol 2005; 32: 1081-5.
11. RUEDA B, PEREZ-ARMENGOL C, LOPEZ-LOPEZ S, GARCIA-PORRUA C, MARTIN J, GONZALEZ-GAY MA: Association between functional haplotypes of vascular endothelial growth factor and renal complications in Henoch-Schönlein purpura. J Rheumatol 2006; 33: 69-73.
12. MUSTELIN T, ALONSO A, BOTTINI N et al.: Protein tyrosine phosphatases in T cell physiology. Mol Immunol 2004; 41: 687-700.
13. BOITINI N, MUSUMECI L, ALONSO A et al.: A functional variant of lymphoid tyrosine phosphatase is associated with type I diabetes. Nat Genet 2004; 36: 337-8.
14. LEE YH, RHO YH, CHOI SJ et al.: The PTPN22 C1858T functional polymorphism and autoimmune diseases - a meta-analysis. Rheumatology (Oxford) 2007; 46: 49-56.
15. OROZCO G, SANCHEZ E, GONZALEZ-GAY MA et al.: Association of a functional single nucleotide polymorphism of PTPN22, encoding lymphoid protein phosphatase, with rheumatoid arthritis and systemic lupus erythematosus. Arthritis Rheum 2005; 52: 219-24.
16. MICHEL BA, HUNDER GG, BLOCH DA, CALABRESE LH: Hypersensitivity vasculitis and Henoch-Schönlein purpura: A comparison between the 2 disorders. J Rheumatol 1992; 19: 721-8.
17. MILLS JA, MICHEL BA, BLOCH DA et al.: The American College of Rheumatology 1990 criteria for the classification of Henoch-Schönlein purpura. Arthritis Rheum 1990; 33: 1114-21.
18. BEGOVICH AB, CARLTON VEH, HONIGBERG LA et al.: A missense single-nucleotide polymorphism in a gene encoding a protein tyrosine phosphatase (PTPN22) is associated with rheumatoid arthritis. Am J Hum Genet 2004; 75: 330-7.
19. GONZALEZ-GAY MA, OLIVER J, OROZCO G, GARCIA-PORRUA C, LOPEZ-NEVOT MA, MARTIN J: Lack of association of a functional single nucleotide polymorphism of PTPN22, encoding lymphoid protein phosphatase, with susceptibility to biopsy-proven giant cell arteritis. J Rheumatol 2005; 32: 1510-2.
20. OROZCO G, GARCIA-PORRUA C, LOPEZ-NEVOT MA, RAYA E, GONZALEZ-GAY MA, MARTIN J: Lack of association between ankylosing spondylitis and a functional polymorphism of PTPN22 proposed as a general susceptibility marker for autoimmunity. Ann Rheum Dis 2006; 65: 687-8.